Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Contraception: later-stage trial registry
16 of 73 indexed Contraception trials are currently recruiting, with more weight in Phase 3-4.
Corpus placement: #188 of 28,707 conditions by registered trial count.
73 US clinical trials · 16 currently recruiting · #188 of 28,707 conditions by registered trial count
Contraception: 73 US clinical trials tracked, 16 recruiting.
Contraception is the subject of 73 registered US clinical trials on ClinicalTrials.gov, 16 of them currently open to new participants. 16 are in Phase 3-4 (later-stage) and 8 in Phase 1-2 (earlier-stage). The most active sponsor is University of Utah, running 6 of these trials.
Enrollment posture brief
Registry condition contraception
OPEN 16 | RECR 22% | LATE 16 | EARLY 8 | RANK #188 | SPON 6
Volume-matched condition peers
Nearest open-share peer: Cardiovascular Risk Factor (22% recruiting · 32 trials)
Contraception lists 16 open slots (22% of 73 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Contraception on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Contraception is recruiting below its size-band peers.
16 of 73 indexed trials (21.9%) are open to enrollment, against a 39.7% average across 762 conditions with 20-99 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Contraception trials is spread across many organizations.
University of Utah accounts for 6 of 73 trials (8.2%). 42 distinct sponsors appear on at least one study for this condition label.
-
Typical Contraception enrolment sits around 150 participants.
Median target enrolment is 150 among the 73 trials that report a genuine target (sentinel values excluded). 30 of those (41.1%) plan for fewer than 100 participants.
-
Contraception research is mostly interventional.
57 interventional and 16 observational studies make up this index (78.1% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
73 total, page 1 of 2
Levonorgestrel 52 mg IUD for Emergency Contraception and Same-Day Start
University of Utah
NCT05444582
Oral Contraceptive Pill (OCP) Pharmacogenomics
Yale University
NCT06334315
Contraceptive Efficacy Study of Ovaprene
Daré Bioscience
NCT06127199
Patient-centered Information on Permanent Contraception
University of California, San Francisco
NCT06296797
A 3-way Crossover Clinical Investigation to Assess the Performance of Two Different Sized Polyurethane Condoms Versus a Latex Condom in Healthy Monogamous Couples.
Reckitt Benckiser Healthcare (UK) Limited
NCT06557499
Prospective Multi-Center Trial for FemBloc Permanent Birth Control
Femasys
NCT05977751
Improving Alcohol and Substance Use Care Access, Outcome, Equity During the Reproductive Years
Emory University
NCT05910580
Implementation of a Patient-centered, Reproductive Planning Decision Support Tool (MyPath) Among Women With Substance Use Disorder in the Immediate Postpartum Period
University of Pittsburgh
NCT04939012
Patient-clinical Linkages to Improve Trust and Engagement in Postpartum Healthcare
Jackson State University
NCT06481631
Empathy Through Pain Control: Lidocaine Paracervical Block for IUD Placements
University of California, San Diego
NCT06960317
Hormonal Contraception Access Through Pharmacist Prescribing Implementation
EMPOWERX
NCT06823037
Intervening on Women's Health for Rural Young Cancer Survivors
University of California, San Diego
NCT06664034
Endometrial Biopsy in Progestin Contraceptive Users
Oregon Health and Science University
NCT05760144
Influences of Long-acting Reversible Contraceptives on Iron Status and Physiological Responses to Extreme Environments in Women
United States Army Research Institute of Environmental Medicine
NCT06909695
Intravenous Ketorolac Administration to Attenuate Post-procedural Pain Associated With Intrauterine Device Placement
Arkansas Children's Hospital Research Institute
NCT05875571
Etonogestrel Implant as Emergency Contraception
University of Colorado, Denver
NCT05237141
Tipping Point: Using Social Network Theory to Accelerate Scale and Impact
University of California, San Diego
NCT05777473
Birth Control to Improve Birth Spacing
Brigham and Women's Hospital
NCT05240066
Quick Start of Highly Effective Contraception
University of Utah
NCT02076217
The Over The Counter Pill National Study
Oregon Health and Science University
NCT05988983
Study of the Safety and Contraceptive Efficacy of Relugolix Combination Therapy in Women With Uterine Fibroids or Endometriosis Who Are at Risk for Pregnancy
Sumitomo Pharma Switzerland
NCT04756037
RCT Evaluating Standardized Counseling on Early Discontinuation for Irregular Bleeding in Nexplanon Users
Planned Parenthood of the St. Louis Region and Southwest Missouri
NCT04558229
Assessing Adolescent Use of Nexplanon Over Time
University of Utah
NCT04889079
Impact of Progestin-only Contraception on Bleeding Patterns in Individuals Initiating GATT
University of California, San Diego
NCT06230770
FemBloc® Permanent Contraception - Confirmation Feasibility Trial
Femasys
NCT04273594
Adolescent Subcutaneous (SQ) Injection Video Validation
Tufts Medical Center
NCT04997499
Family Planning Elevated: Initiative Evaluation
University of Utah
NCT03877757
The HOP-STEP Intervention: Improving Maternal Health in Women With Lupus sIRB
Duke University
NCT05818254
Contraceptive Choice Center
Washington University School of Medicine
NCT02633631
UCSF College Health Study on Contraceptive Training and Education at Community Colleges
University of California, San Francisco
NCT03519685
Study of Safety and Efficacy of an Oral Contraceptive
Warner Chilcott
NCT00477633
Personal Responsibility Education Program Innovative Strategies: Digital Initiative for Youth
University of California, San Francisco
NCT03765255
Effectiveness of Prolonged Use of IUD/Implant for Contraception
Indiana University
NCT02267616
Evaluation of Respecting the Circle of Life on Pregnancy Prevention Outcomes Among American Indian Adolescents
Johns Hopkins Bloomberg School of Public Health
NCT02904629
A Multicenter, Non-Comparative Trial on the Contraceptive Efficacy, Safety, and Tolerability of LPRI-424, 13 Cycles
Insud Pharma
NCT03945513
Study of Immediate Start of Progestin Contraceptives in Medical Abortion
Gynuity Health Projects
NCT01902485
Pharmacogenomics of Contraception: Genetic Variants and Etonogestrel Pharmacokinetics
University of Colorado, Denver
NCT03092037
Online Peer Influence on IUD Behaviors and Attitudes
University of California, San Francisco
NCT02279043
Safety, Tolerability, and Efficacy of ellaOne® (Ulipristal Acetate) for Emergency Contraception in Postmenarcheal Adolescent Girls and Women
HRA Pharma
NCT01107106
Patient-Centered Reproductive Decision Support Tool for Women Veterans
VA Office of Research and Development
NCT04584294
Quantification of Immune Cells in Women Using Contraception (CHIC II)
University of Pittsburgh
NCT01873170
A Multicenter Study to Evaluate the Safety of Seasonique, an Oral Contraceptive.
Duramed Research
NCT00196352
FemBloc® Permanent Contraception - Early Pivotal Trial
Femasys
NCT03433911
Assessing Satisfaction With Contraceptive Counseling Using Telephone Versus Video Telehealth Visits
Washington University School of Medicine
NCT05317468
Contraception Perspectives in Adolescents in Haiti
Children's Mercy Hospital Kansas City
NCT05252052
A Comparison of Short Interval vs. Routine Postpartum Visit on Contraceptive Initiation
Washington University School of Medicine
NCT02769676
NES Gel-1, To Evaluate Nestorone Gel in Combination With Testosterone Gel
University of Washington
NCT00229593
Study of Self or Clinic Administration of DepoProvera
Carolyn L. Westhoff
NCT01019369
Comparison of the Levonorgestrel IUD and the Copper IUD Placed in the Immediate Postplacental Period: A Prospective Cohort Study
University of Colorado, Denver
NCT02067663
Improving Reproductive Health for Women in Opioid Medication-Assisted Treatment (OMAT)
Denver Health and Hospital Authority
NCT02794597
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 7 |
| Phase 2 | 1 |
| Phase 3 | 4 |
| Phase 4 | 12 |
Top Sponsors
Named interventions
Most-linked intervention names on Contraception records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Contraception trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Contraception page
73 registered trials, 16 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 16 Contraception trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- University of Utah sponsors the most Contraception trials on record, review their full trial history before evaluating a specific study. See University of Utah's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Contraception condition card totals 73 registered trials; most-linked intervention FemBloc; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.